SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹288 Cr | ₹385 Cr | ₹457 Cr | ₹330 Cr | ₹383 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUVEN PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹385 Cr |
| Mar2023 | ₹457 Cr |
| Mar2022 | ₹330 Cr |
| Mar2021 | ₹383 Cr |
How is Cash Flow from Operating Activities of SUVEN PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | -25.11 | |
| Mar2024 | ₹385 Cr | -15.84 | |
| Mar2023 | ₹457 Cr | 38.54 | |
| Mar2022 | ₹330 Cr | -13.74 | |
| Mar2021 | ₹383 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹14,592.4 Cr | -8.5% | -28.8% | -64% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -8.5% |
-28.8% |
-64% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses